Levosimendan to Reduce Mortality in High Risk Cardiac Surgery Patients. A Multicentre Randomized Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2016
At a glance
- Drugs Levosimendan (Primary)
- Indications Cardiovascular disorders; Low cardiac output
- Focus Therapeutic Use
- Acronyms CHEETAH
- 21 Jul 2016 Status changed from recruiting to completed.
- 01 Jul 2016 Trial design published in the American Heart Journal
- 28 Nov 2012 Planned number of patients added to 1000 as reported by European Clinical Trials Database record.